Statements (56)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:healthcare_organization
|
| gptkbp:bfsLayer |
6
|
| gptkbp:bfsParent |
gptkb:Piqray
|
| gptkbp:can_metastasize_to |
liver
lungs bones lymph nodes |
| gptkbp:has_style |
gptkb:hormone_receptor-positive_breast_cancer
|
| https://www.w3.org/2000/01/rdf-schema#label |
HR-positive breast cancer
|
| gptkbp:is_affected_by |
environmental factors
hormonal changes genetic mutations |
| gptkbp:is_associated_with |
gptkb:estrogen_receptors
lower recurrence rates higher survival rates progesterone receptors |
| gptkbp:is_characterized_by |
cell proliferation
tumor size hormone receptor expression grade of tumor |
| gptkbp:is_discussed_in |
gptkb:academic_journal
|
| gptkbp:is_evaluated_by |
genetic testing
immunohistochemistry molecular profiling |
| gptkbp:is_linked_to |
age
lifestyle factors obesity family history |
| gptkbp:is_monitored_by |
blood tests
regular imaging |
| gptkbp:is_often_used_in |
gptkb:philosopher
men postmenopausal women |
| gptkbp:is_part_of |
patient support groups
breast cancer research treatment guidelines breast cancer awareness campaigns breast cancer survivorship programs oncology studies breast cancer treatment protocols breast cancer prevention strategies |
| gptkbp:is_studied_in |
clinical trials
|
| gptkbp:recognizes |
biopsy
mammography |
| gptkbp:scientific_classification |
metastatic
early-stage locally advanced |
| gptkbp:social_responsibility |
generally favorable
|
| gptkbp:treatment |
gptkb:hospital
radiation therapy chemotherapy targeted therapy hormone therapy CD K4/6 inhibitors aromatase inhibitors SER Ms |